Encube Ethicals Pvt. Ltd. vs Dermavant Sciences GmbH et al.

Adverse judgment: post-institution

Patent Owner's Motion to Terminate Proceeding and Parties' Joint Motion for Entry of Adverse Judgment

EX2001 - Statutory Disclaimer

Ex. 3005

Petitioner's Notice of Intent to Designate a Provisionally Recognized PTAB Attorney as Back-up Counsel

Certification of Peter M. Kohlhepp

Petitioner's Updated Exhibit List

Webpage printout from https://openstax.org/books/organic-chemistry/pages/1-12-drawing-chemicalstructures

Webpage printout from https://pubchem.ncbi.nlm.nih.gov/compound/6439522#section=MeSHEntryTerms

Webpage printout from https://en.wikipedia.org/wiki/Tapinarof

Webpage printout from https://www.chemicals.co.uk/blog/what-do-vv-ww-wv-mean

Patent Owner's Notice of Liem Deposition

Order: Granting Petitioners Motion to Submit Supplemental Information 37 C.F.R. sec. 42.123a

Patent Owner's Opposition to Petitioner's Motion to Submit Supplemental Information

Joint Stipulation to Modify Due Dates 1, 2, and 3

Petitioner's Motion to Submit Supplemental Information

Order: CONDUCT OF THE PROCEEDING 37 C.F.R. sec. 42.5a

Exhibit 3003

Exhibit 3004

Patent Owner's Objections to Evidence

Patent Owner's Updated Power of Attorney

Patent Owner's Updated Mandatory Notices

Institution Decision: Grant

Order: Scheduling Order

Patent Owner's Sur-Reply to Petitioner's Reply to Patent Owner Preliminary Response

Exhibit 3002

Petitioner's Preliminary Reply to Patent Owner Preliminary Response

Exhibit 3001

Patent Owner's Preliminary Response

Patent Owner's Power of Attorney

Patent Owner's Mandatory Notices

Notice: Notice filing date accorded

U.S. Patent No. 11,590,088

File History of U.S. Patent No. 11,590,088

Curriculum Vitae of Wieke H. Liem, M.D.

U.S. Patent Application Pub. No. 2016/0338973 (“Sonti”)

Dogra, et al., Psoriasis: Epidemiology, Clinical Features, Co-morbidities,

Spuls, et al., How Good Are Clinical Severity and Outcome Measures for Psor

Bissonnette, et al., Efficacy and Safety of Topical WBI-1001 in Patients Wi

Bolkote, et al., An Analysis of Psoriasis Skin Images, International Journa

Cappelleri, et al., Psychometric Validation of the Physician Global Assessm

Patel, et al., Evaluating Psoriasis: A Review of the Assessments Most Commo

U.S. Patent No. 7,868,047 (“Chen”)

Antibiotics in Microbial Ecology, Isolation and Structure Assignment of Sev

Diagnosis and Classification of Psoriasis, 13 Autoimmunity Reviews 490

Chinese Clinical Trial Register Registration Number ChiCTR-TRC-10000995

Chinese Clinical Trial Register Registration Number ChiCTR-TRC-11001391

Chinese Clinical Trial Register Registration Number ChiCTR-TRC-13003259

Natural product and natural product derived drugs in clinical trials

USAP Dictionary of USAN and International Drug Names, 42nd ed., p. 212

Precision FDA, UNII Search, entry for UNII: L0Q8IK9E08 (“Steareth-20”)

Precision FDA, UNII Search, entry for UNII: V56DFE46J5 (“Steareth-2”)

Global Ingredient Archival System, GSRS database entry for Steareth-2

Global Ingredient Archival System, GSRS database entry for Steareth-20

FDA Prescribing Information, VTAMA® (tapinarof) topical cream, 1%

U.S. Patent Publication No. 2003/0171429 (“Chen 1”)

U.S. Patent Publication No. 2010/0094041 (“Chen 2”)

U.S. Patent Publication No. 2008/0255245 (“Chen 3”)

Emulsions and their Characterization by Texture Profile Analysis, Handbook

Excerpts from Handbook of Pharmaceutical Excipients , 8th Edition

Declaration of Paul T. Sudhakar, MS, MBA

Curriculum Vitae of Paul T. Sudhakar

WO 2001/042231

Declaration of Wieke H. Liem, M.D.

Declaration of Sylvia D. Hall-Ellis, Ph.D.

Clinical trials for plaque psoriasis treatments prior to Nov. 2018 (Part 1)

Clinical trials for plaque psoriasis treatments prior to Nov. 2018 (Part 2)

Clinical trials for plaque psoriasis treatments prior to Nov. 2018 (Part 3)

Clinical trials for plaque psoriasis treatments prior to Nov. 2018 (Part 4)

Petition for Inter Partes Review of US 11,590,088

Petitioner's Power of Attorney